TransAct (TACT) CFO reports stock from vesting plus tax withholdings

Rhea-AI Filing Summary

TransAct Technologies President and CFO Steven A. DeMartino reported multiple equity-award vesting events and related tax withholdings in late February and early March. On March 1, 2026, Performance Stock Units granted on March 1, 2023 converted into 7,629 shares of common stock, with some shares withheld to cover taxes. Restricted Stock Units granted in 2022, 2023 and 2024 also vested and converted one-for-one into common shares on February 28, March 1, and March 2, 2026. Several Form 4 entries coded “F” show shares delivered back to the company at prices around $3.46–$3.50 solely to satisfy tax or exercise obligations, rather than open-market sales, leaving DeMartino with a remaining direct holding of common stock.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

DEMARTINO STEVEN A

(Last) (First) (Middle)

ONE HAMDEN CENTER

2319 WHITNEY AVENUE, SUITE 3B

(Street)

HAMDEN CT 06518

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
TRANSACT TECHNOLOGIES INC [ TACT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President, CFO, Treas. & Secr.

3. Date of Earliest Transaction (Month/Day/Year)
02/28/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/28/2026		M		2,075(1)	A	(1)	172,922	D
Common Stock	02/28/2026		F		704	D	$3.46	172,218	D
Common Stock	03/01/2026		M		7,629(2)	A	(2)	179,847	D
Common Stock	03/01/2026		F		2,588	D	$3.46	177,259	D
Common Stock	03/01/2026		M		1,975(3)	A	(3)	179,234	D
Common Stock	03/01/2026		F		670	D	$3.46	178,564	D
Common Stock	03/02/2026		M		1,550(4)	A	(4)	180,114	D
Common Stock	03/02/2026		F		525	D	$3.5	179,589	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	02/28/2026		M			2,075	(1)	(1)	Common Stock	2,075	(1)	4,150	D
Performance Stock Units	(2)	03/01/2026		M			7,629	(2)	(2)	Common Stock	7,629	(2)	0	D
Restricted Stock Units	(3)	03/01/2026		M			1,975	(3)	(3)	Common Stock	1,975	(3)	1,975	D
Restricted Stock Units	(4)	03/02/2026		M			1,550	(4)	(4)	Common Stock	1,550	(4)	0	D

Explanation of Responses:

1. Restricted Stock Units issued on February 29, 2024 pursuant to the Company's 2014 Equity Incentive Plan, as Amended and Restated, vesting 25% annually commencing on the first anniversary of the date of grant that have converted to common stock on a one-for-one basis.

2. Performance Stock Units (PSU) issued on March 1, 2023 pursuant to the Company's 2014 Equity Incentive Plan, as Amended, which vest in three equal installments on March 1, 2024, March 1, 2025 and March 1, 2026 that have converted to common stock on a one-for-one basis.

3. Restricted Stock Units issued on March 1, 2023 pursuant to the Company's 2014 Equity Incentive Plan, as Amended and Restated, vesting 25% annually commencing on the first anniversary of the date of grant that have converted to common stock on a one-for-one basis.

4. Restricted Stock Units issued on March 2, 2022 pursuant to the Company's 2014 Equity Incentive Plan, as Amended and Restated, vesting 25% annually commencing on the first anniversary of the date of grant that have converted to common stock on a one-for-one basis.

	Steven A. DeMartino	03/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did TACT executive Steven DeMartino report on this Form 4?

Steven A. DeMartino reported vesting and conversion of Restricted Stock Units and Performance Stock Units into common stock, plus share dispositions to cover taxes. All awards came from TransAct’s 2014 Equity Incentive Plan under previously granted RSUs and PSUs with scheduled vesting dates.

How many TransAct (TACT) shares came from PSU vesting in this filing?

The filing shows 7,629 shares of TransAct common stock issued upon conversion of Performance Stock Units on March 1, 2026. These PSUs were originally granted March 1, 2023 and vest in three equal installments on March 1, 2024, 2025 and 2026.

Were any of Steven DeMartino’s TACT share transactions open-market sales?

The reported dispositions are coded “F,” meaning shares were surrendered to pay exercise price or tax liabilities. This indicates tax-withholding dispositions to the company, not open-market sales to third-party buyers on a stock exchange or trading venue.

Which TransAct equity plans were involved in these Form 4 transactions?

All RSUs and PSUs referenced were issued under TransAct Technologies’ 2014 Equity Incentive Plan, as amended and restated. Footnotes specify award grant dates in 2022, 2023 and 2024, along with their scheduled annual or installment vesting schedules converting into common stock.

What vesting schedules applied to the RSUs in this TACT Form 4?

RSUs granted on March 2, 2022, March 1, 2023 and February 29, 2024 each vest 25% annually, starting on the first anniversary of grant. As tranches vested in 2026, they converted into common shares on a one-for-one basis according to the disclosed terms.

Does Steven DeMartino hold TransAct (TACT) shares directly after these transactions?

Yes. Each common stock entry shows ownership type coded as direct. After the reported vesting and tax-withholding dispositions on the respective dates, DeMartino continued to hold a direct position in TransAct common stock as reflected by the post-transaction share balances.